The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects o… Mehr…
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects of chlorpromazine in 1952.In his opening address to the 1st CINP Congress in Rome, Rothlin pointed out that these discoveries gave "a great impetus for any kind of scientific approach to brain research" and had "revolutionary consequences in the treatment of psychotic patients".The incentive they provided "was not limited to theoretical and practical medical sciences but caused an even greater stimulus to the imagination of chemists, leading to the production of new compounds with a speed that neither pharmacological, biochemical nor clinical investigations could equitably follow. " The possibility to induce psychopathology by the administration of pharmacological agents and to control naturally occurring psychopathol- ogy by drugs opened unforeseen possibilities for brain research and a new era in psychiatry.In psychiatry, the new psychotropic drugs with their increasingly better defined behavioral, neurophysiological and biochemi- cal actions have provided a new means for therapeutically influencing and systematically studying psychopathological conditions, whereas in the basic sciences, neuropharmacological research, directed to reveal the action mechanism of new drugs, brought about unprecedented progress in the identification of the morphological substrate of different brain func- tions.It also set the stage for the exploration of possible correlations between behavioral, including psychopathological, and neurochemical events.; PDF; Scientific, Technical and Medical > Other branches of medicine > Psychiatry, Springer Berlin Heidelberg<
hive.co.uk
No. 9783642739569. Versandkosten:Instock, Despatched same working day before 3pm, zzgl. Versandkosten. Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects o… Mehr…
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects of chlorpromazine in 1952.In his opening address to the 1st CINP Congress in Rome, Rothlin pointed out that these discoveries gave "a great impetus for any kind of scientific approach to brain research" and had "revolutionary consequences in the treatment of psychotic patients".The incentive they provided "was not limited to theoretical and practical medical sciences but caused an even greater stimulus to the imagination of chemists, leading to the production of new compounds with a speed that neither pharmacological, biochemical nor clinical investigations could equitably follow. " The possibility to induce psychopathology by the administration of pharmacological agents and to control naturally occurring psychopathol- ogy by drugs opened unforeseen possibilities for brain research and a new era in psychiatry.In psychiatry, the new psychotropic drugs with their increasingly better defined behavioral, neurophysiological and biochemi- cal actions have provided a new means for therapeutically influencing and systematically studying psychopathological conditions, whereas in the basic sciences, neuropharmacological research, directed to reveal the action mechanism of new drugs, brought about unprecedented progress in the identification of the morphological substrate of different brain func- tions.It also set the stage for the exploration of possible correlations between behavioral, including psychopathological, and neurochemical events.; PDF; Scientific, Technical and Medical > Other branches of medicine > Psychiatry, Springer Berlin Heidelberg<
hive.co.uk
No. 9783642739569. Versandkosten:Instock, Despatched same working day before 3pm, zzgl. Versandkosten. Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects o… Mehr…
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects of chlorpromazine in 1952.In his opening address to the 1st CINP Congress in Rome, Rothlin pointed out that these discoveries gave "a great impetus for any kind of scientific approach to brain research" and had "revolutionary consequences in the treatment of psychotic patients".The incentive they provided "was not limited to theoretical and practical medical sciences but caused an even greater stimulus to the imagination of chemists, leading to the production of new compounds with a speed that neither pharmacological, biochemical nor clinical investigations could equitably follow. " The possibility to induce psychopathology by the administration of pharmacological agents and to control naturally occurring psychopathol- ogy by drugs opened unforeseen possibilities for brain research and a new era in psychiatry.In psychiatry, the new psychotropic drugs with their increasingly better defined behavioral, neurophysiological and biochemi- cal actions have provided a new means for therapeutically influencing and systematically studying psychopathological conditions, whereas in the basic sciences, neuropharmacological research, directed to reveal the action mechanism of new drugs, brought about unprecedented progress in the identification of the morphological substrate of different brain func- tions.It also set the stage for the exploration of possible correlations between behavioral, including psychopathological, and neurochemical events.; PDF; Scientific, Technical and Medical > Other branches of medicine > Psychiatry, Springer Berlin Heidelberg<
hive.co.uk
No. 9783642739569. Versandkosten:Instock, Despatched same working day before 3pm, zzgl. Versandkosten. Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects o… Mehr…
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects of chlorpromazine in 1952. In his opening address to the 1st The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects of chlorpromazine in 1952. In his opening address to the 1st, Springer<
A Brief History of the Collegium Internationale Neuro-Psychopharmacologicum, eBooks, eBook Download (PDF), [PU: Springer Berlin Heidelberg], Springer Berlin Heidelberg, 2012
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects o… Mehr…
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects of chlorpromazine in 1952.In his opening address to the 1st CINP Congress in Rome, Rothlin pointed out that these discoveries gave "a great impetus for any kind of scientific approach to brain research" and had "revolutionary consequences in the treatment of psychotic patients".The incentive they provided "was not limited to theoretical and practical medical sciences but caused an even greater stimulus to the imagination of chemists, leading to the production of new compounds with a speed that neither pharmacological, biochemical nor clinical investigations could equitably follow. " The possibility to induce psychopathology by the administration of pharmacological agents and to control naturally occurring psychopathol- ogy by drugs opened unforeseen possibilities for brain research and a new era in psychiatry.In psychiatry, the new psychotropic drugs with their increasingly better defined behavioral, neurophysiological and biochemi- cal actions have provided a new means for therapeutically influencing and systematically studying psychopathological conditions, whereas in the basic sciences, neuropharmacological research, directed to reveal the action mechanism of new drugs, brought about unprecedented progress in the identification of the morphological substrate of different brain func- tions.It also set the stage for the exploration of possible correlations between behavioral, including psychopathological, and neurochemical events.; PDF; Scientific, Technical and Medical > Other branches of medicine > Psychiatry, Springer Berlin Heidelberg<
No. 9783642739569. Versandkosten:Instock, Despatched same working day before 3pm, zzgl. Versandkosten.
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects o… Mehr…
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects of chlorpromazine in 1952.In his opening address to the 1st CINP Congress in Rome, Rothlin pointed out that these discoveries gave "a great impetus for any kind of scientific approach to brain research" and had "revolutionary consequences in the treatment of psychotic patients".The incentive they provided "was not limited to theoretical and practical medical sciences but caused an even greater stimulus to the imagination of chemists, leading to the production of new compounds with a speed that neither pharmacological, biochemical nor clinical investigations could equitably follow. " The possibility to induce psychopathology by the administration of pharmacological agents and to control naturally occurring psychopathol- ogy by drugs opened unforeseen possibilities for brain research and a new era in psychiatry.In psychiatry, the new psychotropic drugs with their increasingly better defined behavioral, neurophysiological and biochemi- cal actions have provided a new means for therapeutically influencing and systematically studying psychopathological conditions, whereas in the basic sciences, neuropharmacological research, directed to reveal the action mechanism of new drugs, brought about unprecedented progress in the identification of the morphological substrate of different brain func- tions.It also set the stage for the exploration of possible correlations between behavioral, including psychopathological, and neurochemical events.; PDF; Scientific, Technical and Medical > Other branches of medicine > Psychiatry, Springer Berlin Heidelberg<
No. 9783642739569. Versandkosten:Instock, Despatched same working day before 3pm, zzgl. Versandkosten.
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects o… Mehr…
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects of chlorpromazine in 1952.In his opening address to the 1st CINP Congress in Rome, Rothlin pointed out that these discoveries gave "a great impetus for any kind of scientific approach to brain research" and had "revolutionary consequences in the treatment of psychotic patients".The incentive they provided "was not limited to theoretical and practical medical sciences but caused an even greater stimulus to the imagination of chemists, leading to the production of new compounds with a speed that neither pharmacological, biochemical nor clinical investigations could equitably follow. " The possibility to induce psychopathology by the administration of pharmacological agents and to control naturally occurring psychopathol- ogy by drugs opened unforeseen possibilities for brain research and a new era in psychiatry.In psychiatry, the new psychotropic drugs with their increasingly better defined behavioral, neurophysiological and biochemi- cal actions have provided a new means for therapeutically influencing and systematically studying psychopathological conditions, whereas in the basic sciences, neuropharmacological research, directed to reveal the action mechanism of new drugs, brought about unprecedented progress in the identification of the morphological substrate of different brain func- tions.It also set the stage for the exploration of possible correlations between behavioral, including psychopathological, and neurochemical events.; PDF; Scientific, Technical and Medical > Other branches of medicine > Psychiatry, Springer Berlin Heidelberg<
No. 9783642739569. Versandkosten:Instock, Despatched same working day before 3pm, zzgl. Versandkosten.
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects o… Mehr…
The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects of chlorpromazine in 1952. In his opening address to the 1st The development of modern psychopharmacology was triggered by two major discoveries: the psychomimetic effects of lysergic acid diethylamide (LSD-25) in 1943 and the therapeutic effects of chlorpromazine in 1952. In his opening address to the 1st, Springer<
A Brief History of the Collegium Internationale Neuro-Psychopharmacologicum, eBooks, eBook Download (PDF), [PU: Springer Berlin Heidelberg], Springer Berlin Heidelberg, 2012
1Da einige Plattformen keine Versandkonditionen übermitteln und diese vom Lieferland, dem Einkaufspreis, dem Gewicht und der Größe des Artikels, einer möglichen Mitgliedschaft der Plattform, einer direkten Lieferung durch die Plattform oder über einen Drittanbieter (Marketplace), etc. abhängig sein können, ist es möglich, dass die von eurobuch angegebenen Versandkosten nicht mit denen der anbietenden Plattform übereinstimmen.
EAN (ISBN-13): 9783642739569 Erscheinungsjahr: 12 Herausgeber: Springer Berlin Heidelberg
Buch in der Datenbank seit 2015-04-12T11:45:40+02:00 (Berlin) Detailseite zuletzt geändert am 2023-05-15T10:39:58+02:00 (Berlin) ISBN/EAN: 9783642739569
ISBN - alternative Schreibweisen: 978-3-642-73956-9 Alternative Schreibweisen und verwandte Suchbegriffe: Autor des Buches: hippius, ban thomas, gardiner Titel des Buches: collegium internationale neuro psychopharmacologicum, years
Daten vom Verlag:
Autor/in: Thomas A Ban; Hanns Hippius Titel: Thirty Years CINP - A Brief History of the Collegium Internationale Neuro-Psychopharmacologicum Verlag: Springer; Springer Berlin 138 Seiten Erscheinungsjahr: 2012-12-06 Berlin; Heidelberg; DE Sprache: Englisch 96,29 € (DE) 99,00 € (AT) 118,00 CHF (CH) Available XVII, 138 p. 42 illus.
History of CINP: From Rome to Munich.- The 1st Congress — Rome 1958.- The 2nd Congress — Basle 1960.- The 3rd Congress — Munich 1962.- The 4th Congress — Birmingham 1964.- The 5th Congress — Washington 1966.- The 6th Congress — Tarragona 1968.- The 7th Congress — Prague 1970.- The 8th Congress — Copenhagen 1972.- The 9th Congress — Paris 1974.- The 10th Congress — Quebec 1976.- The 11th Congress — Vienna 1978.- The 12th Congress — Gothenburg 1980.- The 13th Congress — Jerusalem 1982.- The 14th Congress — Florence 1984.- The 15th Congress — San Juan 1986.- The 16th Congress — Munich 1988.- Towards the 17th Congress — Kyoto 1990.- CINP Today.- Africa.- Americas — Canada.- Americas — Latin Americas.- Americas — United States.- Asia — Far East.- Asia — Israel.- Australia.- Europe — Benelux Countries.- Europe — Czechoslovakia.- Europe — Denmark, Finland and Norway.- Europe — France.- Europe — German-Speaking Countries.- Europe — Hungary, Romania and Turkey.- Europe — Italy.- Europe — Poland.- Europe — Portugal and Spain.- Europe — Sweden.- Europe — United Kingdom.- Europe — Yugoslavia.- Concluding Remarks.
Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
